1. Amygdala signal abnormality and cognitive impairment in drug-naïve schizophrenia
- Author
-
Huagui Guo, Haibiao Ye, Zhijian Li, Xuesong Li, Wei Huang, Yu Yang, Guojun Xie, Caixia Xu, Xiaoling Li, Wenting Liang, Huan Jing, Chunguo Zhang, Chaohua Tang, and Jiaquan Liang
- Subjects
Schizophrenia ,MRI ,Cognition ,Amygdala ,PANSS ,RBANS ,Psychiatry ,RC435-571 - Abstract
Abstract Background Recently studies had showed that the amygdala may take part in the cognitive impairment in schizophrenia (SC). However, the mechanism is still unclear, so we explored the relationship between the amygdala resting state magnetic resonance imaging (rsMRI) signal and cognitive function, to provide a reference for the follow-up study. Methods We collected 59 drug-naïve SCs and 46 healthy controls (HCs) from the Third People’s Hospital of Foshan. The rsMRI technique and automatic segmentation tool were used to extract the volume and functional indicators of the SC’s amygdala. The Positive and Negative Syndrome Scale (PANSS) was used to assess the severity of the disease, and the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) was used to assess cognitive function. Pearson correlation analysis was used to compare the relationship between the structural and functional indicators of the amygdala and PANSS and RBANS. Results (1) There was no significant difference between SC and HC in age, gender and years of education. Compared with HC, the PANSS score of SC increased and the RBANS score decreased significantly. Meanwhile, the left amygdala volume decreased (t=-3.675, p
- Published
- 2023
- Full Text
- View/download PDF